These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4463707)

  • 1. The rate of contemporary drug discovery.
    Bloom BM
    Adv Drug Res; 1974; 8():1-10. PubMed ID: 4463707
    [No Abstract]   [Full Text] [Related]  

  • 2. [Family medicine, epidemiological drug research and social pharmacology].
    Alloza JL
    Med Clin (Barc); 1984 Jan; 82(3):124-9. PubMed ID: 6748807
    [No Abstract]   [Full Text] [Related]  

  • 3. New drug development.
    Taylor WJ
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):105-13. PubMed ID: 4895441
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs of limited commercial value.
    Van Woert MH
    N Engl J Med; 1980 Jul; 303(2):114. PubMed ID: 7383068
    [No Abstract]   [Full Text] [Related]  

  • 5. The model veterinary drug code--what could it mean?
    McKean JD
    J Am Vet Med Assoc; 1988 Apr; 192(7):885-90. PubMed ID: 3366674
    [No Abstract]   [Full Text] [Related]  

  • 6. The Federal Food and Drug Administration in the United States: born and bred in crises.
    Taylor WJ
    Int J Clin Pharmacol; 1973 Apr; 7(2):156-62. PubMed ID: 4581340
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical investigation of new drugs.
    N Engl J Med; 1967 Nov; 277(21):1148-9. PubMed ID: 4861565
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulation programs for pediatric drug research--do children really benefit?
    Boots I; Sukhai RN; Klein RH; Holl RA; Wit JM; Cohen AF; Burggraaf J
    Eur J Pediatr; 2007 Aug; 166(8):849-55. PubMed ID: 17225950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescriptions imported into the United States.
    Tenn Med; 2004 Aug; 97(8):337. PubMed ID: 15376708
    [No Abstract]   [Full Text] [Related]  

  • 10. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 11. Veterinary drug availability.
    Gloyd J
    J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety considerations in development of new animal drugs.
    Fogleman RW
    J Am Vet Med Assoc; 1972 Dec; 161(11):1381-4. PubMed ID: 4638516
    [No Abstract]   [Full Text] [Related]  

  • 13. Should the FDA impose relative efficacy judgments?
    Stetler CJ
    Tex Med; 1972 Nov; 68(11):48-52. PubMed ID: 4634627
    [No Abstract]   [Full Text] [Related]  

  • 14. Current trends in IND-NDA procedures.
    Brilhart KB
    Bull Parenter Drug Assoc; 1971; 25(3):132-9. PubMed ID: 5093249
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug lag '80: the missing medicines.
    Rhein RW
    Med World News; 1980 Sep; 21(18):31-48. PubMed ID: 10317008
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceutical postmarket review: fact or fiction?
    Schanz SJ
    Food Drug Law J; 2007; 62(3):493-500. PubMed ID: 17915391
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of orphan products.
    FDA Drug Bull; 1983 Apr; 13(1):2-4. PubMed ID: 6852406
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicines, governments and doctors.
    Dunlop D
    Drugs; 1972; 3(5):305-13. PubMed ID: 4652594
    [No Abstract]   [Full Text] [Related]  

  • 20. A taste of new medicine.
    Nat Med; 2006 May; 12(5):481. PubMed ID: 16675969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.